A detailed history of Fort Washington Investment Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 3,011 shares of NVO stock, worth $316,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,011
Previous 3,011 -0.0%
Holding current value
$316,335
Previous $429,000 16.55%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $6,258 - $7,492
51 Added 1.72%
3,011 $429,000
Q4 2023

Jan 17, 2024

BUY
$87.78 - $105.45 $8,778 - $10,545
100 Added 3.5%
2,960 $306,000
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $130,044 - $285,342
1,430 Added 100.0%
2,860 $260,000
Q1 2023

Apr 28, 2023

BUY
$132.34 - $159.14 $189,246 - $227,570
1,430 New
1,430 $227,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fort Washington Investment Advisors Inc Portfolio

Follow Fort Washington Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.